Key result
Cryoballoon ablation achieves ~74% 1-year freedom from AF, though persistent AF predicts higher recurrence.
Why the study?
Cryoballoon ablation for AF has been studied mostly in Western countries, leaving its efficacy and predictors of AF recurrence unclear in Asian populations.
What is the 1-year efficacy of cryoballoon ablation for rhythm control and what are the baseline predictors of atrial fibrillation recurrence in an Asian cohort?
Cohort (n=120)
No
What is the 1-year efficacy of cryoballoon ablation for rhythm control and what are the baseline predictors of atrial fibrillation recurrence in an Asian cohort?
Cryoballoon ablation is safe and achieves a 74.2% 1-year freedom from AF in Asian patients, with persistent AF, pre-procedural cardioversion, and a higher left atrial diameter cutoff (≥4.75 cm) identifying patients at higher risk of recurrence.
Answers are grounded in this paper and cite their sources.
Supports cryoballoon ablation in Asian patients; extends prior data but leaves open need for randomized validation.
Background: Cryoballoon ablation (CBA) for atrial fibrillation (AF) is a rhythm control procedure used in clinical trials, mostly in Western countries. Its efficacy and the predictors of AF recurrence after CBA remain unclear for Asian populations. We aimed to investigate the efficacy of CBA and the predictors of AF recurrence after CBA in Asian AF patients. Methods: We included consecutive AF patients undergoing CBA for rhythm control between 2014 and 2020. The baseline characteristics, including AF types, symptom severity, and left atrial diameter (LAD), were analyzed. Holter’s monitoring and 12-lead ECG were performed to document AF recurrence. A multivariate Cox hazards regression model was used to evaluate the risk of AF recurrence. Results: A total of 120 AF patients (aged 61.9 ± 9.3 years) were included. The percentage of patients free from AF in the year following CBA was 74.2%. Among the three independent predictors of AF recurrence within one year were the presence of persistent AF (p = 0.025), an LAD ≥ 4.75 cm (p = 0.016), and pre-procedural cardioversion (p = 0.025). All patients survived and none had a stroke after CBA. Conclusion: CBA for AF is an effective and safe procedure in Asian populations. The presence of persistent AF, an LAD ≥ 4.75 cm, and severe symptoms are predictors of AF recurrence in the year following CBA.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2022) conducted a cohort in Paroxysmal or persistent atrial fibrillation (n=120). Cryoballoon ablation was evaluated on Freedom from atrial fibrillation (or any atrial tachyarrhythmia including AF, AFL, and atrial tachycardia) after the 90-day blanking period within 1 year. Cryoballoon ablation achieved 74.2% freedom from atrial fibrillation at 1 year in Asian patients, with persistent AF and LAD ≥4.75 cm predicting recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: